| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 811803-05-1 | Apatinib(Rivoceranib,YN968D1) |
≥98% | | 询价 |
| 2 | 228559-41-9 | Ki8751 |
≥98% | | 询价 |
| 3 | 1174046-72-0 | BMS-794833 |
≥98% | | 询价 |
| 4 | 1225451-84-2 | SKLB1002(SKLB-1002 SKLB 1002) |
≥98% | | 询价 |
| 5 | 208255-80-5 | DAPT |
| 5mg, 10mg, 50mg | 询价 |
| 6 | 1254473-64-7 | LY2874455 |
≥98% | | 询价 |
| 7 | 915769-50-5 | Dovitinib(TKI258 CHIR-258)Lactate |
≥98% | | 询价 |
| 8 | 557795-19-4 | Sunitinib free base(SU-11248) |
≥98% | | 询价 |
| 9 | 883986-34-3 | AZD2932 |
≥98% | | 询价 |
| 10 | 215543-92-3 | SU5402(SU-5402 SU 5402) |
≥98% | | 询价 |
| 11 | 443913-73-3 | Vandetanib(ZD-6474) |
≥98% | | 询价 |
| 12 | 849217-64-7 | Foretinib(GSK-1363089 XL-880 EXEL2880 GSK-089) |
≥98% | | 询价 |
| 13 | 319460-85-0 | Axitinib(AG-013736 Inlyta) |
≥98% | | 询价 |
| 14 | 943319-70-8 | Ponatinib(AP-24534 Iclusig) |
≥98% | | 询价 |
| 15 | 943332-08-9 | Selumetinib sulfate(AZD6244 sulfate) |
≥98% | | 询价 |
| 16 | | Tanzisertib HCl(CC-930) |
≥98% | | 询价 |
| 17 | 899805-25-5 | Tanzisertib(CC-930) |
≥98% | | 询价 |
| 18 | 1454682-72-4 | LY3009120(DP-4978) |
≥98% | | 询价 |
| 19 | 1269440-17-6 | Encorafenib(LGX818) |
≥98% | | 询价 |
| 20 | 1188910-76-0 | Agerafenib(CEP-32496 RXDX-105 AC013773) |
≥98% | | 询价 |
| 21 | 1228591-30-7 | TAK-632 |
≥98% | | 询价 |
| 22 | 220904-83-6 | GW5074 |
≥98% | | 询价 |
| 23 | 284461-73-0 | Sorafenib(Bay 43-9006) |
≥98% | | 询价 |
| 24 | 208260-29-1 | ZM 336372 |
≥98% | | 询价 |
| 25 | 405554-55-4 | SB590885 |
≥98% | | 询价 |
| 26 | 940310-85-0 | NVP-BHG712(BHG712) |
≥98% | | 询价 |
| 27 | 878739-06-1 | AZ 628(AZ-628 AZ628) |
≥98% | | 询价 |
| 28 | 905281-76-7 | GDC-0879 |
≥98% | | 询价 |
| 29 | 1195765-45-7 | Dabrafenib(GSK2118436) |
≥98% | | 询价 |
| 30 | 923564-51-6 | ABT-263 |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 31 | 475207-59-1 | Sorafenib Tosylate(Bay 43-9006 Nexavar) |
≥98% | | 询价 |
| 32 | 918505-84-7 | PLX-4720 |
≥98% | | 询价 |
| 33 | 918504-65-1 | Vemurafenib(PLX4032 RG7204 RO5185426) |
≥98% | | 询价 |
| 34 | 464-92-6 | Asiatic Acid(Dammarolic acid,Asiantic acid) |
≥98% | | 询价 |
| 35 | 303162-79-0 | TAK-715 |
≥98% | | 询价 |
| 36 | 1221485-83-1 | Skepinone-L(CBS3830) |
≥98% | | 询价 |
| 37 | 284028-89-3 | XAV939 |
| 10mg, 25mg, 50mg, 100mg, 200mg | 询价 |
| 38 | 942183-80-4 | SCH772984 |
| 2mg, 5mg, 10mg, 50mg | 询价 |
| 39 | 585543-15-3 | Losmapimod(GW0856553X SB0856553) |
≥98% | | 询价 |
| 40 | 945614-12-0 | Pexmetinib(ARRY-614) |
≥98% | | 询价 |
| 41 | 193551-21-2 | SB239063 |
≥98% | | 询价 |
| 42 | 209410-46-8 | Neflamapimod(VX745,VRT031745 VD31745 |
≥98% | | 询价 |
| 43 | 58-58-2 | Puromycin dihydrochloride |
| 5mg, 10mg, 25mg | 询价 |
| 44 | 586379-66-0 | PH-797804 |
≥98% | | 询价 |
| 45 | 745833-23-2 | VX-702 |
≥98% | | 询价 |
| 46 | 862507-23-1 | Ralimetinib dimysylate(LY2228820 dimysylate) |
≥98% | | 询价 |
| 47 | 152121-30-7 | SB202190(FHPI) |
≥98% | | 询价 |
| 48 | 285983-48-4 | BIRB 796(Doramapimod) |
≥98% | | 询价 |
| 49 | 152121-47-6 | Adezmapimod(SB203580 RWJ-64809) |
≥98% | | 询价 |
| 50 | 22862-76-6 | Anisomycin(NSC-76712,AI 3-50846,Flagecidin,Wuningmeisu C) |
≥98% | | 询价 |
| 51 | 1809784-29-9 | DTP3 |
≥98% | | 询价 |
| 52 | 312917-14-9 | TCS JNK 5a |
≥98% | | 询价 |
| 53 | 1410880-22-6 | JNK-IN-8 |
≥98% | | 询价 |
| 54 | 129-56-6 | SP600125(SP600125 NSC75890) |
≥98% | | 询价 |
| 55 | 869886-67-9 | Ulixertinib(BVD-523 VRT752271) |
≥98% | | 询价 |
| 56 | 181223-80-3 | DEL-22379 |
≥98% | | 询价 |
| 57 | 896720-20-0 | VX-11e |
≥98% | | 询价 |
| 58 | 1435488-37-1 | XMD17-109 |
≥98% | | 询价 |
| 59 | 1453848-26-4 | Ravoxertinib(GDC-0994 RG-7842) |
≥98% | | 询价 |
| 60 | 865362-74-9 | FR 180204 |
≥98% | | 询价 |
m.cnreagent.com